m+Medelevator.RU
← Поиск публикаций
Annual reviews in control · 2025

Cyber-Physical-Human Systems in Precision Medicine: Advances in Artificial Pancreas for Treatment of Diabetes.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ahmadasas Mohammad, Inanc Emirhan, Ozkara Efe, Siket Mate, Rashid Mudassir M, Bilgic Mustafa, Quinn Laurie, Cinar Ali

Аннотация

Cyber-physical-human systems (CPHS) hold the potential to transform healthcare delivery and patient outcomes for numerous chronic diseases, such as diabetes, through remote patient monitoring, automatic control, and precision medicine. Expedited by the recent advances in artificial intelligence, including model development, control systems, data assimilation, network infrastructure, and cybersecurity, the application of digital twins has proliferated across various industry sectors, and have recently been applied to medical settings. Digital twins of people with type 1 diabetes (T1D) and the pancreas can well represent the complex metabolic, physiologic, and pharmacologic processes underlying the chronic disease. This enables intelligent CPHSs that can automate insulin delivery without any manual user announcements to mitigate the effects of various disturbances to glucose homeostasis such as meals, physical activities, acute psychological stress, and sleep pattern variations. Automated insulin delivery in people with T1D, also called artificial pancreas, is a successful application of digital twins in medicine that advances T1D treatment, reducing the burden of the chronic condition and improving the lives of people with T1D. We present a hybrid modeling framework that integrates mechanistic physiological models with data-driven empirical models to develop accurate digital twins of people with T1D, which is then used in an artificial intelligence-enabled automated insulin delivery system. Simulation and clinical experiments integrating virtual patients or individuals with T1D with an artificial pancreas system illustrate the performance of the CPHS, demonstrating the capabilities of rendering fully-automated real-time treatment decisions for precision medicine. Future avenues of research and development in CPHS for precision medicine are also highlighted, including online learning algorithms, adaptive fault-tolerant systems, and robust cybersecurity.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты